Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.425 USD | +6.25% | +11.11% | +29.45% |
15/05 | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
14/05 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.45% | 40.23M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.26% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+25.72% | 12.26B | |
+27.17% | 12.05B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Transcript : Daré Bioscience, Inc., Q1 2023 Earnings Call, May 11, 2023